Abstract Background: COPD patients have to deal not only with the physical consequences of the disease, but they must also deal with the psychological consequences of COPD. Anxiety and depression are highly prevalent co morbidities in COPD.
Introduction
Chronic obstructive pulmonary disease (COPD) is a major cause of chronic morbidity and mortality throughout the world and it is the fourth leading cause of death worldwide [1] . Patients with COPD frequently find themselves in a vicious cycle of dyspnea, deteriorating exercise performance, restricted mobility and social isolation [2] .
COPD patients have to deal not only with the physical consequences of the disease, but they must also deal with the psychological consequences of COPD [3] .
Anxiety and depression are highly prevalent co morbidities in COPD [4] . Investigating anxiety and depression in COPD patients is challenging because of the subjective nature of the diagnostic process, the variability in presentation and the significant overlap of symptoms between COPD, anxiety and depression (i.e. dyspnea, chest tightness, palpitations, tremor, fatigue, disordered sleep and loss of appetite) [5, 6] .
Importantly, symptoms of anxiety and depression in COPD were shown to be associated with a worse course of disease, including reduced quality of life and increased symptoms burden, health-care use, and even mortality [7] .
Depression has always received greater attention in these patients while, anxiety in COPD patients has received even less attention than depression, despite the fact that anxiety and depression usually occur together in these patients [4] .
The mental disorders themselves can be further aggravated by patients' disabilities and, in turn, they can exaggerate patients' COPD symptoms. When recognized, they are, however, treatable and should be treated since health is regarded as a state of complete physical, social and mental wellbeing [8] .
The aim of the present study was to assess the symptoms of depression and anxiety in COPD patients and to correlate between the severity of the anxiety and depression with the severity of the COPD.
Subjects and methods
This is a cross-sectional pilot study that was carried out in the outpatient clinic and inpatient ward of the chest department, Ain Shams University hospitals. One hundred sixty candidates participated in the study. They were 80 COPD patients (diagnosed according to GOLD 2013 [9] ) and 80 matched healthy subjects as a control group.
All patients were subjected to:
-Full history taking with concern to duration of the illness, prior admission to intensive care, oxygen therapy or mechanical ventilation as added stressors that may contribute to different psychological outcomes. -Thorough clinical examination.
-Chest X-ray and CT chest if needed. -Spirometric assessment (using Flowscreen Spirometer, Viasys) was done after administration of adequate dose of short-acting inhaled bronchodilator to minimize variability. -Classification of severity of airflow limitation in COPD (patients with FEV1/FVC < 0.7) was done based on post bronchodilator FEV1, according to GOLD 2013 [9] : Mild COPD: FEV1 > 80% of predicted.
Moderate COPD: 50% 6 FEV1 P 80% of predicted.
Severe COPD: 30% 6 FEV1 P 50% of predicted. Very severe COPD: FEV1 < 30% of predicted. -Arterial blood gases (ABG) was done (using Radiometer ABL 800 flex) and patients were classified according to partial pressure of arterial oxygen tension (PaO 2 ) into: patients with PaO 2 > 80 mmHg, patients with PaO 2 60-80 mmHg and patients with PaO 2 < 60 mmHg to ease the correlation between different levels of PaO 2 and other parameters.
Eighty healthy subjects with matched age, sex and socioeconomic conditions were recruited as a control group. They were selected from the employees and visitors of patients coming to the Ain Shams University hospitals in all departments.
All candidates were subjected to:
-Structured Clinical Interview for DSM IV axis I disorders (SCID-I-Clinician version) [10] : The SCID has 7 diagnostic modules, focused on different diagnostic groups: mood, psychotic, substance abuse, anxiety, somatoform, eating and adjustment disorders. Its use in this study was to ascertain the presence of a psychiatric diagnosis; the clinician version was used rather than the research version for its relatively easier administration and coverage of the diagnoses most commonly encountered in clinical settings. -Hamilton anxiety scale (HAM-A) [ Patients with other chest diseases, past history of psychiatric disorders, past history of other chronic medical disorder as diabetes mellitus, hypertension. . .etc. were excluded from the study.
Statistical analysis
Continuous variables are expressed as mean and Standard Deviation. Categorical variables are expressed as frequencies and percents. Student t test and ANOVA test was used to assess the statistical significance of the difference between two and more than two study groups means respectively. Chi Square and Fisher's exact test were used to examine the relationship between Categorical variables. Pearson's correlation was used to assess the correlation between quantitative variables. Multivariate Linear regression was used to test and estimate the dependence of a quantitative variable based on its relationship with a set of independent variables a significance level of P < 0.05 was used in all tests. All statistical procedures were carried out using SPSS version 15 for Windows (SPSS Inc, Chicago, IL, USA).
This study is the first of 2 publications in a research project assessing psychiatric symptomatology and cognitive functions in COPD patients.
Results
The current study was conducted on 80 COPD patients diagnosed and their level of severity was determined according to GOLD 2013. Eighty healthy age, sex and socio-economic matched subjects were also included in the study as a control group. The descriptive data of both groups are shown in Table 1 .
By using Student-t test and Chi-Square test in comparing between COPD patients and control groups as regards personal data (age, gender, smoking habits, occupation, marital state and residence), there was no statistical significant difference between both groups.
Psychiatric characteristics in the form of presence or absence of psychiatric disorder, anxiety and depression scores and levels of severity of them together with the presence or absence of substance abuse were described in the COPD patients group and control group in Table 2 .
This Table 3 shows a highly statistical significant difference between COPD and control groups as regards the presence of psychiatric disorder, depression score, severity of depression and severity of anxiety. On the other hand, there was no significant difference in comparing both groups as regards anxiety score, while substance abuse showed significant difference between both the COPD and control groups.
The Table 4 showed a significant negative t correlation between age and anxiety score ( Fig. 1) , on the other hand a direct significant correlation was found between PaO 2 and anxiety score (Fig. 2 ). FEV1 showed a significant negative correlation with depression score (Fig. 3) .
There was no correlation between all personal data of the groups (apart from age) and anxiety or depression scores.
In comparing between COPD cases with different severities as regards personal and psychiatric data, there were more anxiety symptoms in patients with severe COPD compared to other groups (p = 0.047), while patients with severe and very severe COPD had more depressive symptoms compared to other groups (p = 0.016) as shown in Table 5 .
In comparing between cases with different levels of PaO 2 as regards age, duration of illness and psychiatric disorders (Table 6 ) there was a highly significant relationship between the presence of depression and PaO 2 levels 60-80 mmHg and a significant relationship between different levels of PaO 2 and different levels of depression. On the other hand, there was no significant difference between different levels of PaO 2 and age, duration of illness, substance abuse and the presence of anxiety. However, anxiety severity correlated directly with PaO 2 levels. In the present study the drug abusers showed no significant difference in anxiety and depression scores in comparison with non drug abusers. Mean anxiety score was 10.5 ± 4.54 and 12.0 ± 4.97 in drug abusers and non drug abusers respectively. While, depression scores were 9.0 ± 4.75 and 9.12 ± 4.3 respectively.
Also in comparison between previously ICU admitted cases and non ICU admitted cases as regards anxiety and depression scores, the anxiety score was 10.92 ± 5.3 and 12.19 ± 4.71 respectively and the depression score was 10.0 ± 5.69 and 8.67 ± 3.5 respectively with no statistically significant difference between both cases.
As regards cases with a history of mechanical ventilation the mean anxiety score was 10.75 ± 2.05 and 11.89 ± 5.13 in cases with no history of mechanical ventilation respectively, while the depression score was 10.5 ± 6.61 and 8.94 ± 4.05 respectively with no statistical significance between both cases. Also in the current study patients who received oxygen therapy showed no significant difference than patients who did not receive oxygen therapy with anxiety scores of 10.83 ± 5.37 and 12.18 ± 4.69 respectively and depression scores of 9.67 ± 5.54 and 8.86 ± 3.74 respectively.
Discussion
Patients with COPD may experience a higher prevalence of psychological distress, like symptoms of anxiety and depression, than the general healthy population [13] . Increasing evidence suggests that anxiety and depression may have direct impacts on health status, hospitalization and exacerbation of COPD, rather than being consequences or markers of disease severity. Thus, detecting depression or anxiety in patients with COPD is of great importance [7] . Therefore, the aim of the present study was to assess the symptoms of depression and anxiety in COPD patients and to correlate between the severity of the anxiety and depression with the severity of the COPD.
In the present study 44 patients out of 80 (55%) showed psychiatric disorders, while in the control group 16 subjects out of 80 (20%) showed psychiatric disorders. The most common psychiatric disorders were depression (42.5% in COPD patients and 10% in control group) followed by anxiety (22.5% in COPD group and 8% in control group), whereas substance abuse was detected in 15% of COPD cases and in 5% of the control group.
This coincides with Regvat et al. [8] who investigated the prevalence of anxiety and depression in 50 chronic obstructive pulmonary disease (COPD) patients and found that 50% of patients entering the rehabilitation program showed anxiety and/or depression.
It also coincides with other investigators [14] who studied the prevalence of anxiety and depression in 701 COPD patients and found that about 41.8% of patients had anxiety and/or depression symptoms.
Another study [15] agreed with our results and stated that 43% of COPD patients were diagnosed with depression and 29% of them were diagnosed with anxiety. It also agrees with other studies [16, 17] who stated that scores of depression and anxiety were higher in the COPD patient in comparison with the control group.
Our study showed that 15% of the COPD patients had substance abuse in comparison with 5% in the control group. This coincides with another study [18] stated that 7.7% of COPD patients had substance abuse disorders. In the present study patients with severe and very severe COPD (according to GOLD 2013) showed significantly higher depression and anxiety scores in comparison with mild and moderate COPD patients. There was also a significant negative correlation between depression severity and FEV1, whereas anxiety severity showed no significant correlation with FEV1.
This agrees with Janssen et al., [14] who studied relevant symptoms of anxiety and depression in 701 COPD patients entering pulmonary rehabilitation and found that patients with severe COPD had a significantly higher depression and anxiety scores than mild and moderate groups. Also in another study [19] they stated that decreased FEV1 is correlated with the development of depression and anxiety among COPD patients.
Another study agreed with our study [17] and stated that increased frequency of depression was associated with severity of COPD. While anxiety frequency was not significant among COPD patients, its scores were higher among COPD patients than in the controls. It also coincides to some extent with Lou et al., [20] who stated that increased frequency of anxiety symptoms was correlated with increased COPD severity according to the GOLD stages. However, they also found that no significant difference was observed between patients with or without depression or anxiety regarding FEV1.
On the other hand, other study [14] showed no significant correlation between severity of COPD and scores of depression and anxiety.
In the current study there was a highly significant relationship between the presence of depression and PaO 2 level especially PaO 2 level 60-80 mmHg and a significant relationship between different levels of PaO 2 and different levels of depression. As regards anxiety the current study showed no significant correlation between the anxiety score and PaO 2 level, however there was a highly significant direct correlation between PaO 2 levels and severity levels of anxiety.
This coincides with other investigators [21] stated that patients with depression had lower PaO 2 levels.
Also, coincides partially with Regvat et al., [15] who found that depression and/or anxiety in COPD patients were associated with higher levels of PaO 2 . They suggested that this may be explained as the patients with anxiety and/or depression are referred and admitted to the hospital earlier in exacerbation.
On the other hand, other investigators [17, 14] found that there was no correlation between PaO 2 levels and psychiatric disorders.
In the present study duration of illness, history of ICU admission, history of previous mechanical ventilation and oxygen therapy did not show significant correlation with depression or anxiety scores.
This coincides with another study [14] investigated the symptoms of anxiety and depression COPD patients and stated that duration of COPD illness is not correlated with depression or anxiety scores. Other investigators [20, 21] who studied the symptoms of anxiety and depression in COPD patients entering pulmonary rehabilitation found that oxygen therapy has no significance in depression or anxiety scores.
To some extent it also coincides [22] with other investigators who studied the prevalence of anxiety and depression in COPD patients and associated factors, they found that previous admission to the emergency room is not correlated with depression or anxiety.
On the other hand, another study [21] found that oxygen therapy and non invasive mechanical ventilation showed significant correlation with symptoms of depression and anxiety in COPD patients. Also, other investigators [23] found that patients stayed in ICU for different causes (average stay 8 days) showed 20-30% mood disorders in the form of depression and/or anxiety.
In the present study both patients and control groups were matched as regards age, sex and socio-economic status. There was no statistical significance between both groups as regards personal data (smoking habits, duration of smoking, marital status, residence and occupation). There was no correlation between depression and anxiety scores with all these personal data apart from age, as anxiety score showed negative correlation with age.
This coincides, in most of personal data, with many studies [14, 15, 21] stated that age, sex, occupation, residence and smoking status has no correlation with depression and anxiety symptoms in COPD patients.
However, other studies mentioned [20, 22] that females were more common having depression and/or anxiety than males. Some of these studies found that depression and anxiety symptoms were associated with middle and older age and increased in current smoking.
Finally, Obradovid et al. [17] stated that age and gender has no significance in depression, while smoking is related to depression symptoms.
Conclusions
This study proves the association between COPD and symptoms of anxiety and depression. The severity of anxiety and depression were correlated with the severity of COPD and the presence of lower PaO 2 . Age, sex, duration of illness and previous ICU admission or mechanical ventilation did not correlate with depression or anxiety symptoms.
It shows that it is important to screen for symptoms of anxiety and depression in COPD patients for possibility of depression and anxiety treatment which may improve the clinical outcome of the patients. However, further studies are needed for the impact of these disorders on the COPD course and their effect on exacerbation, morbidity and mortality of the disease. Also, studies are needed to investigate the effect of depression and anxiety therapy on COPD patients and their prognosis.
